[HTML][HTML] Anti-mitochondrial antibody titers decrease over time in primary biliary cholangitis patients with ursodeoxycholic acid therapeutic response: a cohort study …
ML Chang, WT Chen, TM Chan, CY Lin… - Frontiers in …, 2022 - frontiersin.org
Background How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study …
ML Chang, WT Chen, TM Chan… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
[HTML][HTML] Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort …
ML Chang, WT Chen, TM Chan, CY Lin… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study …
ML Chang, WT Chen, TM Chan, CY Lin… - Frontiers in …, 2022 - pure.lib.cgu.edu.tw
Background: How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study …
ML Chang, WT Chen, TM Chan, CY Lin… - Frontiers in …, 2022 - europepmc.org
Background How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study …
ML Chang, WT Chen, TM Chan, CY Lin… - Frontiers in …, 2022 - pure.lib.cgu.edu.tw
Background: How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …